BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
02. April 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
01. April 2024 16:05 ET
|
Biostem Technologies
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
21. März 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
30. Januar 2024 16:05 ET
|
Biostem Technologies
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
11. Januar 2024 08:30 ET
|
Biostem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer role
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
19. Dezember 2023 08:30 ET
|
Biostem Technologies
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
14. Dezember 2023 08:30 ET
|
Biostem Technologies
The Center for Medicare Services (CMS) has established national pricing for AmnioWrap2(TM) in all Medicare Administrative Contractors (MAC) regions
BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
13. Dezember 2023 08:30 ET
|
Biostem Technologies
POMPANO BEACH, Fla., Dec. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
13. November 2023 17:17 ET
|
Biostem Technologies
POMPANO BEACH, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services
08. November 2023 08:30 ET
|
Biostem Technologies
POMPANO BEACH, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of...